Artificial Intelligence Unveils New Antibiotic Treasures

Artificial intelligence (AI) has opened a proverbial chest that had been sealed for nearly 4 billion years. Within this treasure trove wasn’t gold or jewels, but something significantly more valuable: a collection of  molecules capable of combating superbacteria . This groundbreaking discovery comes from a team led by Spanish biotechnologist  César de la Fuente  at the University of Pennsylvania. By examining the genome of  archaea , one of the planet’s oldest lineages of life, researchers have identified a new family of antibiotics known as  archesins .

The Invisible and Growing Threat of Antimicrobial Resistance

The World Health Organization (WHO) considers  antimicrobial resistance (AMR)  to be one of the  greatest threats to humanity . In 2019, it was estimated that almost  5 million deaths  worldwide were associated with infections caused by bacteria that had developed defenses against existing antibiotics. This escalation in bacterial resistance mandates a concerted effort to discover new antibiotics.

The issue is especially severe in vulnerable regions, such as conflict zones or places with fragile healthcare systems. Here, inappropriate antibiotic usage can lead to the emergence of these so-called ‘ superbacteria ’. In Spain, situations such as using antibiotics to treat  viral infections  or failing to complete prescribed treatment can also significantly contribute to this pressing problem.

Archaea: The Resilient Survivors of Extreme Environments

Archaea are unicellular microorganisms characterized by their exceptional resilience. They are considered to be evolutionary predecessors of bacteria, forming their own distinct domain of life alongside bacteria and eukaryotes (the category that includes plants and human cells). Archaea thrive in harsh environments that would be lethal to most living organisms, enduring  extreme temperatures , high acidity, and significant pressure found in oceanic depths.

The Advantage of Resistance

It is this remarkable resilience that led De la Fuente’s research team to explore the  defense mechanisms  of archaea. “Since the discovery of penicillin, the quest for new antibiotics has focused almost exclusively on bacteria and fungi. Our work revolutionizes this paradigm by uncovering antibiotics from a domain of  life that has been virtually unexplored ,” De la Fuente remarked in an interview with El País.

“The potential for discovering antibiotics in archaea is monumental.”

AI: The Key to Discovering Molecular Treasures

To navigate through the over  20,000 species  of archaea, the research team developed a specialized AI named  ‘Apexoracle’ . This advanced tool was instrumental in identifying  90 candidate compounds  that met specific criteria, of which 93% exhibited  antimicrobial properties . By leveraging AI capabilities, the researchers significantly reduced the time required to screen for effective antibiotics.

Health industry advancements

Introducing Archaeasins: A New Defense Against Superbacteria

Among the compounds identified is  archeanine-73 , which has demonstrated effectiveness in laboratory settings comparable to  polymyxin B —an antibiotic used as a last-resort treatment for stubborn infections. This discovery paves the way for a new generation of antibiotics capable of combating ultra-resistant bacteria.

A Revolutionary Approach

This innovative combination of  computational power  and biological research is indicative of a field ripe for potential breakthroughs. Similar AI technologies are currently being deployed to conduct early diagnoses in cancer, aiding radiologists, and investigating why certain superbacteria might not respond to traditional treatments.

In summary, the ongoing conflict against antimicrobial resistance necessitates  new strategies  and inventive approaches. The advances brought forth through the synergy of AI and biotechnology not only illuminate the dark corners of microbial resilience but also offer a hopeful glimpse into novel antibiotic solutions. The fight against superbacteria may be bolstered by discoveries like archesins, ensuring that medical science remains one step ahead in preserving human health.



General News – 2